Chapter title |
Targeted agents and systemic therapy in hepatocellular carcinoma.
|
---|---|
Chapter number | 15 |
Book title |
Multidisciplinary Treatment of Hepatocellular Carcinoma
|
Published in |
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, September 2012
|
DOI | 10.1007/978-3-642-16037-0_15 |
Pubmed ID | |
Book ISBNs |
978-3-64-216036-3, 978-3-64-216037-0
|
Authors |
Ang C, O'Reilly EM, Abou-Alfa GK, Celina Ang, Eileen M. O’Reilly, Ghassan K. Abou-Alfa |
Abstract |
Cytotoxic chemotherapy, hormonal agents, and immunotherapy have been tested in hepatocellular cancer (HCC) with marginal efficacy to date. Recent insights into the molecular pathogenesis of HCC have identified several aberrant signaling pathways that have served as targets for novel therapeutic agents. These discoveries have been translated into the clinical realm with the use of the antiangiogenic and the Raf kinase inhibitor, sorafenib, and have revealed the potential of targeted agents to produce clinically meaningful survival benefits in patients with advanced HCC. Efforts continue in the quest to improve the outcome of HCC patients through the development and evaluation of other targeted agents, and to better understand the interactions between the underlying disease biology and response to therapy. Several pathways are now implicated in hepatocarcinogenesis and agents that target these pathways continue to be developed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 22 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 27% |
Student > Doctoral Student | 2 | 9% |
Student > Bachelor | 2 | 9% |
Librarian | 1 | 5% |
Student > Master | 1 | 5% |
Other | 3 | 14% |
Unknown | 7 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 55% |
Biochemistry, Genetics and Molecular Biology | 2 | 9% |
Agricultural and Biological Sciences | 1 | 5% |
Unknown | 7 | 32% |